S&P TSX Capped Composite...

US Dollar vs CAD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

QNCX Quince Therapeutics Inc

0.7857

0.0057 (0.73%)

After Hours

Last Updated: 17:55:34

Delayed by 15 minutes

Form 3 - Initial statement of beneficial ownership of securities

Quince Therapeutics (NASDAQ:QNCX)
Historical Stock Chart
From Jun 2024 to Jul 2024

Click Here for more Quince Therapeutics Charts.

Quince Therapeutics (NASDAQ:QNCX)
Historical Stock Chart
From Jul 2023 to Jul 2024

Click Here for more Quince Therapeutics Charts.

Quince Therapeutics Inc News

Quince Therapeutics Announces First Patient Dosed in Phase 3 Clinical Trial of EryDex for the Treatment of Ataxia-Telangiectasia
Tuesday 25 June 2024 (1 month ago) • Business Wire

Form 4 - Statement of changes in beneficial ownership of securities
Friday 7 June 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 7 June 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 7 June 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 6 June 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 5 June 2024 (2 months ago) • Edgar (US Regulatory)

Quince Therapeutics Receives U.S. FDA Fast Track Designation for EryDex System
Monday 3 June 2024 (2 months ago) • Business Wire

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Monday 13 May 2024 (2 months ago) • Edgar (US Regulatory)

Quince Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results
Monday 13 May 2024 (2 months ago) • Business Wire

Quince Therapeutics to Present at The Citizens JMP Life Sciences Conference
Monday 6 May 2024 (3 months ago) • Business Wire

Quince Therapeutics Provides Business Update and Reports Fourth Quarter and Fiscal 2023 Financial Results
Monday 1 April 2024 (4 months ago) • Business Wire

Quince Therapeutics Launches Scientific Advisory Board
Thursday 22 February 2024 (5 months ago) • Business Wire

More Quince Therapeutics Inc News Articles

Customers Bancorp

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions